Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

Researchers have studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They did this by creating nanogels combined with a special ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically ...

Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, California, ...

Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several ...

Pharma giant Pfizer and Arvinas’s human epidermal growth factor receptor 2 (HER2) negative breast cancer therapy, ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

BALVERSA (erdafitinib) has strong market potential in the FGFR-altered urothelial carcinoma space, particularly as a targeted therapy for patients wi ...

Gall bladder cancer is a type of tumour that begins in the gall bladder, the organ located on the right side of the abdomen that stores bile, a digestive fluid produced by the liver. The most ...

If left untreated, endometrial cancer can spread to the bladder or rectum, or it can spread to the vagina, fallopian tubes, ovaries, and more distant organs. Fortunately, endometrial cancer ...